Upmc and pitt develop new cancer immunotherapy with avalon globocare

Pittsburgh, aug. 04, 2021 (globe newswire) -- a new collaboration among upmc hillman cancer center, the university of pittsburgh and new jersey-based biotechnology company avalon globocare corp. (nasdaq: avco) aims to develop new cancer immunotherapy approaches and streamline manufacturing processes to bring these powerful treatments to cancer patients within days instead of weeks.
AVCO Ratings Summary
AVCO Quant Ranking